Cargando…
Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report
BACKGROUND: Ganciclovir is a therapeutic choice for extremely premature infants with severe postnatal cytomegalovirus disease, but little is known about its optimal dose size and dosing interval for them. CASE PRESENTATION: We treated an extremely premature female infant with postnatal cytomegalovir...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994216/ https://www.ncbi.nlm.nih.gov/pubmed/27550172 http://dx.doi.org/10.1186/s12887-016-0683-x |
_version_ | 1782449282008219648 |
---|---|
author | Sunada, Mariko Kinoshita, Daisuke Furukawa, Naoko Kihara, Minako Nishimura, Akira Moriuchi, Masako Moriuchi, Hiroyuki |
author_facet | Sunada, Mariko Kinoshita, Daisuke Furukawa, Naoko Kihara, Minako Nishimura, Akira Moriuchi, Masako Moriuchi, Hiroyuki |
author_sort | Sunada, Mariko |
collection | PubMed |
description | BACKGROUND: Ganciclovir is a therapeutic choice for extremely premature infants with severe postnatal cytomegalovirus disease, but little is known about its optimal dose size and dosing interval for them. CASE PRESENTATION: We treated an extremely premature female infant with postnatal cytomegalovirus infection with intravenous administration of ganciclovir since 49 days of life (postmenstrual age of 31 weeks). After ganciclovir treatment was initiated at a dose of 5 mg/kg every 12 h, cytomegalovirus loads in the peripheral blood were markedly decreased. However, since plasma ganciclovir trough level was too high, the interval was extended to every 24 h. Subsequently, the trough level and the estimated 12-h area under the concentration–time curve (AUC(0–12)) were decreased from 3.5 mg/L to 0.3 mg/L and 53.9 mg · h/L to 19.2 mg · h/L, respectively, resulting in an exacerbation of viremia and clinical condition. Adjustment of dosing interval from 24 h to 12 h led to a peak level of 4.2 mg/L, trough level of 1.1 mg/L, and AUC(0–12) of 31.8 mg · h/L, resulting in a marked suppression of viral load. CONCLUSIONS: Monitoring the therapeutic drug levels and cytomegalovirus loads is useful in obtaining a proper treatment effect and preventing overdosage during ganciclovir therapy in premature infants with postnatal cytomegalovirus infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12887-016-0683-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4994216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49942162016-08-24 Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report Sunada, Mariko Kinoshita, Daisuke Furukawa, Naoko Kihara, Minako Nishimura, Akira Moriuchi, Masako Moriuchi, Hiroyuki BMC Pediatr Case Report BACKGROUND: Ganciclovir is a therapeutic choice for extremely premature infants with severe postnatal cytomegalovirus disease, but little is known about its optimal dose size and dosing interval for them. CASE PRESENTATION: We treated an extremely premature female infant with postnatal cytomegalovirus infection with intravenous administration of ganciclovir since 49 days of life (postmenstrual age of 31 weeks). After ganciclovir treatment was initiated at a dose of 5 mg/kg every 12 h, cytomegalovirus loads in the peripheral blood were markedly decreased. However, since plasma ganciclovir trough level was too high, the interval was extended to every 24 h. Subsequently, the trough level and the estimated 12-h area under the concentration–time curve (AUC(0–12)) were decreased from 3.5 mg/L to 0.3 mg/L and 53.9 mg · h/L to 19.2 mg · h/L, respectively, resulting in an exacerbation of viremia and clinical condition. Adjustment of dosing interval from 24 h to 12 h led to a peak level of 4.2 mg/L, trough level of 1.1 mg/L, and AUC(0–12) of 31.8 mg · h/L, resulting in a marked suppression of viral load. CONCLUSIONS: Monitoring the therapeutic drug levels and cytomegalovirus loads is useful in obtaining a proper treatment effect and preventing overdosage during ganciclovir therapy in premature infants with postnatal cytomegalovirus infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12887-016-0683-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-22 /pmc/articles/PMC4994216/ /pubmed/27550172 http://dx.doi.org/10.1186/s12887-016-0683-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Sunada, Mariko Kinoshita, Daisuke Furukawa, Naoko Kihara, Minako Nishimura, Akira Moriuchi, Masako Moriuchi, Hiroyuki Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report |
title | Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report |
title_full | Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report |
title_fullStr | Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report |
title_full_unstemmed | Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report |
title_short | Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report |
title_sort | therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994216/ https://www.ncbi.nlm.nih.gov/pubmed/27550172 http://dx.doi.org/10.1186/s12887-016-0683-x |
work_keys_str_mv | AT sunadamariko therapeuticdrugmonitoringofganciclovirforpostnatalcytomegalovirusinfectioninanextremelylowbirthweightinfantacasereport AT kinoshitadaisuke therapeuticdrugmonitoringofganciclovirforpostnatalcytomegalovirusinfectioninanextremelylowbirthweightinfantacasereport AT furukawanaoko therapeuticdrugmonitoringofganciclovirforpostnatalcytomegalovirusinfectioninanextremelylowbirthweightinfantacasereport AT kiharaminako therapeuticdrugmonitoringofganciclovirforpostnatalcytomegalovirusinfectioninanextremelylowbirthweightinfantacasereport AT nishimuraakira therapeuticdrugmonitoringofganciclovirforpostnatalcytomegalovirusinfectioninanextremelylowbirthweightinfantacasereport AT moriuchimasako therapeuticdrugmonitoringofganciclovirforpostnatalcytomegalovirusinfectioninanextremelylowbirthweightinfantacasereport AT moriuchihiroyuki therapeuticdrugmonitoringofganciclovirforpostnatalcytomegalovirusinfectioninanextremelylowbirthweightinfantacasereport |